Miconazole Topical Creams/Ointments Suppliers & Bulk Manufacturers
Available Forms: Topical Creams/Ointments
Available Strengths: 2%, 4%
Reference Brands: Daktarin(EU)
Category:
Anti-fungal
Miconazole topical creams inhibit fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis essential for fungal cell membranes. They effectively treat dermatophyte and yeast skin infections. Benefits include targeted application, rapid symptom relief, broad antifungal activity, minimal systemic absorption, and a favorable safety profile, making them reliable for superficial fungal infections.
Miconazole Topical Creams/Ointments is available in Topical Creams/Ointments
and strengths such as 2%, 4%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Miconazole Topical Creams/Ointments is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Miconazole Topical Creams/Ointments can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Miconazole topical creams are approved in the EU and US for treating fungal skin infections. In the EU, brands like Daktarin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA-approved miconazole creams, such as Lotrimin, are backed by comprehensive clinical data and pharmacovigilance. Both regions require detailed dossiers for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate efficient market entry for miconazole topical formulations, ensuring adherence to European and American standards for safe, effective antifungal therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing